Sanarus Technologies

www.sanarus.com

Sanarus has developed, patented, and tested a proprietary minimally invasive breast therapy system. The Visica 2TMTreatment System is an image-guided cryoablation device for the treatment of breast tumors as an alternative to surgical lumpectomy. This breast conserving treatment is available at participating breast centers throughout the U.S. The Visica 2 Treatment System has FDA clearance for non-cancerous breast tumors (fibroadenomas). Sanarus is currently sponsoring the FROST Clinical Study for early stage breast cancer that does not involve surgical resection. Our team is constantly working to spread awareness of cryoablation as a treatment option throughout the community as well as major breast cancer organizations throughout the country. We understand that patient awareness and physician adoption are both important factors in making cryoablation the standard of care for breast tumors, and are dedicated to making it available to patients seeking an alternative to surgery. www.sanarus.com www.twitter.com/SanarusTech

Read more

Reach decision makers at Sanarus Technologies

Lusha Magic

Free credit every month!

Sanarus has developed, patented, and tested a proprietary minimally invasive breast therapy system. The Visica 2TMTreatment System is an image-guided cryoablation device for the treatment of breast tumors as an alternative to surgical lumpectomy. This breast conserving treatment is available at participating breast centers throughout the U.S. The Visica 2 Treatment System has FDA clearance for non-cancerous breast tumors (fibroadenomas). Sanarus is currently sponsoring the FROST Clinical Study for early stage breast cancer that does not involve surgical resection. Our team is constantly working to spread awareness of cryoablation as a treatment option throughout the community as well as major breast cancer organizations throughout the country. We understand that patient awareness and physician adoption are both important factors in making cryoablation the standard of care for breast tumors, and are dedicated to making it available to patients seeking an alternative to surgery. www.sanarus.com www.twitter.com/SanarusTech

Read more
icon

Country

icon

State

California

icon

City (Headquarters)

Pleasanton

icon

Employees

11-50

icon

Founded

2009

icon

Estimated Revenue

$5,000,000 to $10,000,000

icon

Social

  • icon
  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Chief Financial Officer

    Email ****** @****.com
    Phone (***) ****-****
  • Member Board of Directors

    Email ****** @****.com
    Phone (***) ****-****
  • Materials Manager

    Email ****** @****.com
    Phone (***) ****-****
  • Clinical Education Specialist

    Email ****** @****.com
    Phone (***) ****-****

Technologies

(10)

Reach decision makers at Sanarus Technologies

Free credits every month!

My account

Sign up now to uncover all the contact details